Softwr

Research · head to head

Dotmatics vs Scispot

Dotmatics logo

Dotmatics

Research

Research informatics group behind GraphPad Prism, SnapGene, Geneious and LabArchives, now owned by Siemens

From
On request
Rated
-
Scispot logo

Scispot

Research

No-code lab operating system combining LIMS, ELN and inventory for biotech teams

From
On request
Rated
-

The short version

  • Each has a real cost: Dotmatics the portfolio was assembled by acquisition and integration between the constituent products is uneven, so buying several Dotmatics brands does not deliver a single connected environment and often means the same manual export steps as before.; Scispot pricing is presented as four dollar sign bands with no figures, so a vendor whose marketing attacks competitor pricing opacity requires a discovery call before telling you its own numbers.
  • They diverge on capability: Dotmatics covers Dotmatics platform, Scispot covers No-code configuration.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Dotmatics and Scispot actually diverge.

Attributes where Dotmatics and Scispot differ
AttributeDotmaticsScispot
PlatformsWeb, Windows, macOS, On-premiseWeb, API

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Dotmatics

  • Dotmatics platform
  • GraphPad Prism
  • SnapGene
  • Geneious Prime and Biologics
  • LabArchives
  • Flow cytometry tools
  • Protein Metrics
  • Siemens ownership

Only in Scispot

  • No-code configuration
  • LIMS and ELN together
  • Inventory management
  • Instrument integration
  • Audit trails and e-signatures
  • API and data layer
  • Validation support
  • Integrations

What people use each for

The jobs each tool is most often brought in to do.

Dotmatics

  • A pharmaceutical company consolidating compound registration, assay data and biology screening onto one informatics layernot Scispot
  • A biotech that already owns Prism, SnapGene and Geneious separately and wants to understand what a group contract would covernot Scispot
  • A university licensing LabArchives across departments as an institutional electronic lab notebooknot Scispot
  • A biologics group needing sequence analysis, flow cytometry and proteomics tools from one supplier with a single procurement routenot Scispot

Scispot

  • A Series A biotech replacing a folder of spreadsheets before a partner or investor audit exposes the gapnot Dotmatics
  • A diagnostics company that needs sample chain of custody and electronic signatures without a year-long LIMS implementationnot Dotmatics
  • A contract research organisation configuring different workflows per client without buying a separate instance each timenot Dotmatics
  • A computational team that wants laboratory data queryable through an API rather than exported by handnot Dotmatics

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Dotmatics

  • The portfolio was assembled by acquisition and integration between the constituent products is uneven, so buying several Dotmatics brands does not deliver a single connected environment and often means the same manual export steps as before.
  • The Siemens acquisition completed in July 2025 with stated revenue synergy targets, which usually translates into pressure to move individually bought desktop licences into larger platform agreements, and small buyers of a single Prism or SnapGene seat should expect that pressure at renewal.
  • Nothing about the enterprise platform is publicly priced, and even the individual applications are increasingly moved to subscription, so total cost across a research group is hard to establish before negotiation.
  • Each acquired product retains its own licence terms, support channel and release cycle, so an organisation using four Dotmatics brands manages four different renewal dates, entitlement models and support experiences.
  • Enterprise deployments require data migration and configuration services, and validated instances for regulated use add both cost and an ongoing customer revalidation duty after each release, so the informatics platform is a programme rather than a purchase.

Scispot

  • Pricing is presented as four dollar sign bands with no figures, so a vendor whose marketing attacks competitor pricing opacity requires a discovery call before telling you its own numbers.
  • Compliance capability is bundled into tier scope rather than itemised, which makes it hard to tell at purchase whether the tier you are quoted actually covers the Part 11 controls your auditor will ask for.
  • Validation remains your responsibility: the vendor supplies support and correctly states that no platform makes a lab compliant, but the documentation effort and its cost sit with your quality function.
  • It is a young and small vendor holding your primary scientific record, so business continuity, data escrow and full export guarantees need to be settled contractually rather than assumed.
  • Instrument integration breadth is narrower than the established LIMS vendors, so labs with older or unusual analysers may need custom connector work that undercuts the no-code promise.

Pricing, plan by plan

Dotmatics

On request
  • Dotmatics platform$undefined/year
    • Enterprise informatics platform priced per user per year on quotation
    • Chemistry and biology registration, assay data and ELN modules scoped separately
    • Implementation and data migration services quoted as a separate programme

Scispot

On request
  • Scispot$undefined/year
    • Custom annual pricing released after a discovery call
    • Four relative investment tiers shown only as dollar sign bands
    • Mid tier adds roles, e-signatures, approvals, audit trails and validation support

Which should you pick?

Choose Dotmatics if

  • You need dotmatics platform.
  • You work on Web, Windows, macOS, On-premise.
  • You also want graphpad prism.

Choose Scispot if

  • You need no-code configuration.
  • You work on Web, API.
  • You also want lims and eln together.

Questions people ask

Is Dotmatics or Scispot better?
Neither clearly leads. Dotmatics starts at On request and Scispot at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Dotmatics or Scispot?
Dotmatics starts at On request and Scispot at On request.
Does Dotmatics or Scispot run on more platforms?
Dotmatics runs on Web, Windows, macOS, On-premise. Scispot runs on Web, API.
What is Dotmatics best used for?
Dotmatics is most often used for a pharmaceutical company consolidating compound registration, assay data and biology screening onto one informatics layer, a biotech that already owns prism, snapgene and geneious separately and wants to understand what a group contract would cover, a university licensing labarchives across departments as an institutional electronic lab notebook, a biologics group needing sequence analysis, flow cytometry and proteomics tools from one supplier with a single procurement route. Of those, a pharmaceutical company consolidating compound registration, assay data and biology screening onto one informatics layer and a biotech that already owns prism, snapgene and geneious separately and wants to understand what a group contract would cover are not what Scispot is typically brought in for.
What can Dotmatics do that Scispot cannot?
Dotmatics covers Dotmatics platform, GraphPad Prism, SnapGene, Geneious Prime and Biologics. Scispot covers No-code configuration, LIMS and ELN together, Inventory management, Instrument integration.

Answered from the vendors’ own pages

Dotmatics: Who owns Dotmatics?

Siemens, which completed a 5.1 billion dollar acquisition on 1 July 2025. Dotmatics now sits inside Siemens Digital Industries Software.

Scispot: How much does Scispot cost?

It does not publish figures. The pricing page shows four relative investment tiers as dollar sign bands, with real numbers given after a discovery call.

Dotmatics: Is GraphPad Prism a Dotmatics product?

Yes. So are SnapGene, Geneious, LabArchives, FCS Express, OMIQ, Protein Metrics, SoftGenetics and nQuery.

Scispot: Does it support 21 CFR Part 11?

It can be configured for Part 11 controlled workflows with roles, e-signatures, approvals and audit trails from the mid tier, and it supports ALCOA+ principles. Validation of your configuration is still your responsibility.

Dotmatics: Do the products work together?

To varying degrees. They were acquired separately and integration across the portfolio is uneven, so verify the specific pair you care about before assuming it.

Scispot: Is it a LIMS or an ELN?

Both, plus inventory, in one subscription rather than separately licensed products.

Dotmatics: Is enterprise pricing published?

No. The informatics platform is quoted per user per year with modules and services scoped separately.

Scispot: Who is it not for?

Large regulated manufacturers with existing validated LIMS estates, and any lab that needs deep integration with an unusual analyser fleet.

Share

Related pages

Other head to heads